Recent Articles

• 
  Vaccine

  GC Biopharma Tdap Vaccine Wins MOHW Excellence Award

  Shin Yoon-chul, Head of Development at GC Green Cross (right), and Baek Young-ha, Director of the Division of Health and Medical Technology Development at the Ministry of Health and Welfare, pose for a commemorative photo at the awards ceremony of the 2026 Vaccine Practical Technology Development Pr

  2026.09.18
• 
  Diagnostics / Monitoring

  Blood Test Detects 87% of Early Pancreatic Cancers

  A blood test has been developed that can detect not only stage 1 and 2 pancreatic cancer, but also precancerous lesions before they progress to cancer. The photo is not directly related to the article content. Getty Images Bank A testing method has been developed that uses a blood test to detect abo

  2026.09.18
• 
  Medical / Research

  Autism May Soon Allow Tailored Treatments

  Autism spectrum disorder (ASD) is depicted in various works of popular culture, including dramas and films. Woo Young-woo (left photo), the protagonist of the drama “Extraordinary Attorney Woo,” and Cho-won, the protagonist of the film “Marathon,” are both characters with ASD. ASD symptoms and their

  2026.09.18
• 
  Medical / Research

  Korean Team Identifies Two Autism-Related Brain Changes

  Getty Images Bank Domestic researchers have for the first time discovered that autism spectrum disorder manifests in the brain as two distinct types of change. Autism spectrum disorder has been difficult to treat because it is associated with more than 1,200 causative genes, so treatment has been li

  2026.09.18
• 
  MedTech

  Humanoid Robot Assists Surgeon With Endoscope Control

  On 16 September at the Samsung Life Insurance Irwon Station Building in Irwon-dong, Gangnam-gu, Seoul, Professor Oh Nam-gi of the Division of Transplantation Surgery at Samsung Medical Center, who served as operating surgeon during a humanoid surgical-assistant robot demonstration hosted by Samsung

  2026.09.17
• 
  Biopharma

  SK Biopharm Licenses Parkinson’s Drug Candidate Worth KRW 430.8 Billion

  On the 17th at SK Biopharmaceuticals’ Pangyo headquarters, First Biotherapeutics CEO Kim Jae-eun (left) and SK Biopharmaceuticals Head of Strategy Yoo Chang-ho pose for a commemorative photo at the signing ceremony for an in-licensing agreement for a new drug candidate for Parkinson’s disease. Court

  2026.09.17
• 
  Biopharma

  Celltrion’s Remsima Tops 48% Japan Share in 11 Years

  Celltrion’s Remsima SC product image. Provided by Celltrion Celltrion announced on the 17th that its flagship autoimmune disease treatment “Remsima” (ingredient name: infliximab) has risen to No. 1 in market share in Japan.According to pharmaceutical market research firm IQVIA and local data, Remsim

  2026.09.17
• 
  Biopharma

  Half-Price Obesity Drugs? Epe Challenges Wegovy, Mounjaro

  The domestic new drug “Epe,” a glucagon-like peptide-1 (GLP-1) class therapy, is entering the obesity treatment market that has been dominated by Wegovy and Mounjaro. Attention is focusing on whether the arrival of this third entrant will reignite competition in obesity drugs. As the entry of Mounja

  2026.09.17
• 
  Clinical Trial

  Celltrion Starts Phase 4 Trial to Expand U.S. Zympentra Use

  Panoramic view of a Celltrion plant. Provided by Celltrion Celltrion announced on the 15th that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a phase 4 clinical trial in the United States to secure evidence for a 240mg high-dose reg

  2026.09.15
• 
  Global Business

  Korea United Pharma to Supply Cancer Drug to Malaysian National Hospital

  Chan Karming, President of Ucogen (left), and Kang Duk-young, CEO of Korea United Pharm Inc. (right). Provided by Korea United Pharm Korea United Pharm Inc. has cleared the high entry barriers of public tenders for national medical institutions in Southeast Asia. The company announced on the 14th th

  2026.09.15